Population
Ovarian cancer cell lines and human ovarian tissue samples
Comparison
Overexpression of IGFBP2 and siRNA attenuation… vs Control cells
Design
Preclinical
Authors
Loading...
Should not yet change ovarian cancer practice; hypothesis-generating for IGFBP2 as therapeutic target.
IGFBP2 enhances the invasion capacity of ovarian cancer cells, suggesting it may be a potential target for cancer therapy.
Lee et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: